DMKJ
David M. Knott Jr Portfolio holdings
AUM
$221M
This Quarter Return
+1.58%
1 Year Return
+22.52%
3 Year Return
+148.91%
5 Year Return
–
10 Year Return
–
AUM
$251M
AUM Growth
+$251M
(-11%)
Cap. Flow
-$31.8M
Cap. Flow
% of AUM
-12.68%
Top 10 Holdings %
Top 10 Hldgs %
68.46%
Holding
113
New
7
Increased
18
Reduced
9
Closed
14
Top Buys
| 1 |
DocGo
DCGO
|
$3.54M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$1.94M |
| 3 |
VRNA
Verona Pharma
VRNA
|
$1.27M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$788K |
| 5 |
MREO
Mereo BioPharma
MREO
|
$742K |
Top Sells
| 1 |
FTAI Aviation
FTAI
|
$16.8M |
| 2 |
Westrock Coffee
WEST
|
$4.89M |
| 3 |
Panagram BBB-B CLO ETF
CLOZ
|
$4.75M |
| 4 |
Janus Henderson AAA CLO ETF
JAAA
|
$3.65M |
| 5 |
Ligand Pharmaceuticals
LGND
|
$2.53M |
Sector Composition
| 1 | Healthcare | 30.83% |
| 2 | Materials | 28.51% |
| 3 | Financials | 14.07% |
| 4 | Communication Services | 8.23% |
| 5 | Technology | 1.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LK
26
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
| $2.11M | 0.84% |
100,000
| – | – |
|
|
27
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.94M | 0.77% |
+314,307
| New | +$1.94M |
|
28
Xeris Biopharma Holdings
XERS
$1.26B
| $1.85M | 0.74% |
820,000
+220,000
| +37% | +$495K |
|
29
Protagonist Therapeutics
PTGX
$3.67B
| $1.82M | 0.72% |
52,368
| – | – |
|
30
AllianceBernstein
AB
$4.38B
| $1.66M | 0.66% |
49,000
| – | – |
|
31
Vertex Pharmaceuticals
VRTX
$100B
| $1.41M | 0.56% |
3,000
| – | – |
|
32
SPDR S&P Biotech ETF
XBI
$5.07B
| $1.3M | 0.52% |
14,000
-2,000
| -13% | -$185K |
|
33
Ryman Hospitality Properties
RHP
$6.22B
| $1.2M | 0.48% |
12,000
| – | – |
|
34
Evolus
EOLS
$494M
| $1.18M | 0.47% |
108,682
+28,682
| +36% | +$311K |
|
35
Mondelez International
MDLZ
$79.5B
| $916K | 0.37% |
14,000
| – | – |
|
36
AbbVie
ABBV
$372B
| $864K | 0.34% |
5,037
| – | – |
|
|
MREO
37
Mereo BioPharma
MREO
$272M
| $850K | 0.34% |
236,000
+206,000
| +687% | +$742K |
|
38
Kimberly-Clark
KMB
$42.8B
| $829K | 0.33% |
6,000
| – | – |
|
39
Editas Medicine
EDIT
$231M
| $827K | 0.33% |
177,000
+37,000
| +26% | +$173K |
|
40
Xenon Pharmaceuticals
XENE
$2.98B
| $814K | 0.32% |
20,866
-3,000
| -13% | -$117K |
|
41
DuPont de Nemours
DD
$32.2B
| $799K | 0.32% |
9,930
| – | – |
|
42
Microsoft
MSFT
$3.77T
| $715K | 0.29% |
1,600
| – | – |
|
43
Roivant Sciences
ROIV
$8.15B
| $666K | 0.27% |
63,000
+9,800
| +18% | +$104K |
|
44
Corteva
CTVA
$50.4B
| $624K | 0.25% |
11,563
| – | – |
|
45
Canadian Natural Resources
CNQ
$65.9B
| $598K | 0.24% |
16,800
+8,400
| +100% | +$299K |
|
46
Dow Inc
DOW
$17.5B
| $591K | 0.24% |
11,136
| – | – |
|
47
BridgeBio Pharma
BBIO
$9.89B
| $532K | 0.21% |
21,000
+5,000
| +31% | +$127K |
|
48
Apple
AAPL
$3.45T
| $525K | 0.21% |
2,494
| – | – |
|
49
Panagram AAA CLO ETF
CLOX
$220M
| $500K | 0.2% |
19,572
-73,384
| -79% | -$1.87M |
|
50
Coca-Cola
KO
$297B
| $484K | 0.19% |
7,600
| – | – |
|